We are an innovative clinical-stage biotechnology company developing tumor-directed immunotherapies for the treatment of cancer.
Lund, Sweden
Joined October 2017
- Tweets310
- Following50
- Followers390
- Likes41
Alligator Bioscience retweeted
Alligator Bioscience’s Q3 is out – comments from the CEO #LifeSciences #BioStockSwe @AlligatorBio biostock.se/en/2022/10/allig…
Alligator Bioscience retweeted
Tune into Episode 55 of the Benchtop Bios Podcast Series, featuring Søren Bregenholt, CEO of @AlligatorBio, who will discuss Alligator’s latest clinical data in the development of tumor-directed immunotherapies. Listen here: lifesci.events/AlligatorPod
Alligator Bioscience AB reports H1 2022 and Q2 2022 financial results and provides a business update news.cision.com/alligator-bi…
Alligator Bioscience to Present Additional data of ATOR-1017 First-in-Human Study via poster presentation at ASCO Annual Meeting 2022 news.cision.com/alligator-bi…
Alligator Bioscience expands its Board of Directors with the appointment of Staffan Encrantz and Denise Goode news.cision.com/alligator-bi…
Bulletin from the annual general meeting in Alligator Bioscience AB on May 5, 2022 news.cision.com/alligator-bi…
Alligator Bioscience AB: Interim report January–March 2022 news.cision.com/alligator-bi…
Invitation to the Presentation of Alligator Bioscience´s Interim Report January - March 2022 on April 27, 2022 news.cision.com/alligator-bi…
Notice of annual general meeting in Alligator Bioscience AB news.cision.com/alligator-bi…
Alligator Bioscience Announces Completion of 600 mg Dose Cohort for ATOR-1017, Dose-escalation and Enrollment for 900 mg dose Cohort Commences news.cision.com/alligator-bi…
Change in number of shares and votes in Alligator Bioscience AB news.cision.com/alligator-bi…
Alligator Bioscience Announces mitazalimab OPTIMIZE-1 Trial Update: Successful Completion of Phase Ib, Phase II enrolling at 900 µg/kg news.cision.com/alligator-bi…
Issue and repurchase of series C shares for performance-based share saving program news.cision.com/alligator-bi…
Alligator Bioscience publishes Annual Report for 2021 news.cision.com/alligator-bi…
Invitation to the Presentation of Alligator Bioscience´s Year-End Report January - December 2021 on February 11, 2022 news.cision.com/alligator-bi…
Alligator Bioscience Appoints Sumeet Ambarkhane MD as Chief Medical Officer news.cision.com/alligator-bi…
Nomination Committee Appointed in Respect of AGM 2022 in Alligator Bioscience AB news.cision.com/alligator-bi…
Alligator Bioscience Announces Commencement of a Sponsored Research Agreement with the University of Pennsylvania Led by Dr. Gregory Beatty news.cision.com/alligator-bi…